- Nachrichtendetail
-
30.05.2024 19:00:09 - Medacta 25th Anniversary World Tour continues with events in Australia and the United States focusing on Personalized and Sustainable Total Knee Arthroplasty
===
Medacta Group SA / Key word(s): Miscellaneous/Miscellaneous
Medacta 25th Anniversary World Tour continues with events in Australia and the United States focusing on Personalized
and Sustainable Total Knee Arthroplasty
2024-05-30 / 19:00 CET/CEST
MEDIA RELEASE
Medacta 25^th Anniversary World Tour continues with events in Australia and the United States focusing on Personalized
and Sustainable Total Knee Arthroplasty
CASTEL SAN PIETRO, May 30, 2024 - On the occasion of its 25^th anniversary, Medacta Group SA ("Medacta," SIX:MOVE)
announces the 4^th Australian M.O.R.E. Knee Symposium in Sydney (AU) which will take place from May 30 to June 1, 2024,
and the 2^nd Kinematic Alignment Summit in Chicago (US) scheduled for June 7-8. These two events are part of a global
scientific series, following the successful 10^th M.O.R.E. International Symposium, held in Lugano, Switzerland, from
April 15-19, 2024, focused on "the sustainability of personalized medicine and technology in orthopedics and spine
surgery.".
"We are honored to welcome surgeons from all over the world and pleased to continue celebrating our 25^th anniversary
by hosting these upcoming scientific events focused on the knee, the segment that has changed the most for Medacta over
the past five years, with our expanding and proven expertise in Kinematic Alignment" states Francesco Siccardi, CEO of
Medacta "These events underscore our commitment and dedication to medical education, promoting the sharing of
experience and knowledge among distinguished surgeons from around the world to improve care, outcomes, and patient
well-being."
"It's important to leverage a comprehensive and versatile knee portfolio to help my patients during the different
stages of knee pathologies," says Dr. Bu Balalla, Sydney, Australia. The 4^th Australian M.O.R.E. Knee Symposium
perfectly aligns with this approach, exploring the latest advancements in knee procedures, covering topics from sports
medicine to revision, with the aim of improving both natural joint motion and biomechanics, ultimately leading to
improved patient outcomes. The complete Medacta knee portfolio supports surgeons with an innovative, personalized, and
sustainable offering. It leverages the integration of MySolutions Personalized Ecosystem technologies, including the
NextAR Knee Augmented Reality surgical application and MyKnee Patient-Matched solution, with the GMK Efficiency
single-use instrument, holding the promise of improving accuracy, precision, and efficiency in knee surgeries.
Moreover, these scientific events will bring together renowned experts in the field to explore innovative approaches to
knee arthroplasty, with a particular focus on Kinematic Alignment. "Kinematic Alignment has become one of the
most-discussed concepts in TKA. Growing out of the desire to deliver a personalized approach to arthroplasty, KA has
shown promising results in published literature with the potential to positively impact patient outcomes," states Dr.
Keith Berend, New Albany, Ohio, USA. Kinematic Alignment, a surgical technique designed to restore the knee's function
to its pre-arthritic state, has been shown to improve patient outcomes through numerous peer-reviewed studies. The
event in the United States provides the perfect opportunity to discuss the initial results of the GMK SpheriKA implant,
the first knee implant specifically designed for Kinematic Alignment procedures. Additionally, Medacta's MyKA platform
offers surgeons a comprehensive solution to perform Kinematic Alignment safely and consistently.
As Medacta celebrates its 25^th anniversary this year, CEO Francesco Siccardi reflects on the company's ongoing
commitment to medical education and innovation: "We are proud to celebrate our 25^th anniversary by continuing to
support our solutions and technologies through world-class medical education. Our dedication to advancing orthopedic
care is unwavering, and we remain focused on what matters the most: improving patient outcomes worldwide."
Medacta 25^th Anniversary World Tour concludes in Tokyo from October 12^th to 14^th.
For more information:
. Medacta's 10^th MORE International Symposium announcement
. Medacta's 10^th MORE International Symposium website
. Medacta's history
Contact
Gianluca Olgiati
Group Vice President Marketing
+41 91 696 60 60
media@medacta.ch
Medacta is a global key player specializing in the design, production, and distribution of innovative, personalized,
and sustainable solutions for joint replacement, sports medicine, and spine surgery. Established in 1999 in
Switzerland, Medacta is committed to improving the care and well-being of patients and maintains a strong focus on
healthcare sustainability. Through close collaboration with expert surgeons globally, continuous investments in R&D,
and the adoption of cutting-edge technologies, Medacta's innovation prioritizes minimally invasive surgery and
personalized solutions for every patient. Through the M.O.R.E. Institute, Medacta supports surgeons with a
comprehensive and tailored program dedicated to the advancement of medical education. Medacta is headquartered in
Castel San Pietro, Switzerland, and operates in over 60 countries. Follow us on Medacta TV, YouTube, LinkedIn and X.
RELATED TRADEMARKS
Medacta Group Related Trademarks are registered at least in Switzerland. The products and services listed below may not
be all-inclusive, and other Medacta products and services not listed below may be covered by one or more trademarks.
The below products and services may be covered by additional trademarks not listed below. Note that Swiss trademarks
may have foreign counterparts. MySolutionsT Personalized Ecosystem, NextART, GMK^®SpheriKA.
Additional features:
Strada Regina
6874 Castel San Pietro
Switzerland
End of News EQS News Service
===
1913935 2024-05-30 CET/CEST
Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1913935&application_name=news
END) Dow Jones Newswires
May 30, 2024 13:00 ET (17:00 GMT)
Medacta Group SA / Key word(s): Miscellaneous/Miscellaneous
Medacta 25th Anniversary World Tour continues with events in Australia and the United States focusing on Personalized
and Sustainable Total Knee Arthroplasty
2024-05-30 / 19:00 CET/CEST
MEDIA RELEASE
Medacta 25^th Anniversary World Tour continues with events in Australia and the United States focusing on Personalized
and Sustainable Total Knee Arthroplasty
CASTEL SAN PIETRO, May 30, 2024 - On the occasion of its 25^th anniversary, Medacta Group SA ("Medacta," SIX:MOVE)
announces the 4^th Australian M.O.R.E. Knee Symposium in Sydney (AU) which will take place from May 30 to June 1, 2024,
and the 2^nd Kinematic Alignment Summit in Chicago (US) scheduled for June 7-8. These two events are part of a global
scientific series, following the successful 10^th M.O.R.E. International Symposium, held in Lugano, Switzerland, from
April 15-19, 2024, focused on "the sustainability of personalized medicine and technology in orthopedics and spine
surgery.".
"We are honored to welcome surgeons from all over the world and pleased to continue celebrating our 25^th anniversary
by hosting these upcoming scientific events focused on the knee, the segment that has changed the most for Medacta over
the past five years, with our expanding and proven expertise in Kinematic Alignment" states Francesco Siccardi, CEO of
Medacta "These events underscore our commitment and dedication to medical education, promoting the sharing of
experience and knowledge among distinguished surgeons from around the world to improve care, outcomes, and patient
well-being."
"It's important to leverage a comprehensive and versatile knee portfolio to help my patients during the different
stages of knee pathologies," says Dr. Bu Balalla, Sydney, Australia. The 4^th Australian M.O.R.E. Knee Symposium
perfectly aligns with this approach, exploring the latest advancements in knee procedures, covering topics from sports
medicine to revision, with the aim of improving both natural joint motion and biomechanics, ultimately leading to
improved patient outcomes. The complete Medacta knee portfolio supports surgeons with an innovative, personalized, and
sustainable offering. It leverages the integration of MySolutions Personalized Ecosystem technologies, including the
NextAR Knee Augmented Reality surgical application and MyKnee Patient-Matched solution, with the GMK Efficiency
single-use instrument, holding the promise of improving accuracy, precision, and efficiency in knee surgeries.
Moreover, these scientific events will bring together renowned experts in the field to explore innovative approaches to
knee arthroplasty, with a particular focus on Kinematic Alignment. "Kinematic Alignment has become one of the
most-discussed concepts in TKA. Growing out of the desire to deliver a personalized approach to arthroplasty, KA has
shown promising results in published literature with the potential to positively impact patient outcomes," states Dr.
Keith Berend, New Albany, Ohio, USA. Kinematic Alignment, a surgical technique designed to restore the knee's function
to its pre-arthritic state, has been shown to improve patient outcomes through numerous peer-reviewed studies. The
event in the United States provides the perfect opportunity to discuss the initial results of the GMK SpheriKA implant,
the first knee implant specifically designed for Kinematic Alignment procedures. Additionally, Medacta's MyKA platform
offers surgeons a comprehensive solution to perform Kinematic Alignment safely and consistently.
As Medacta celebrates its 25^th anniversary this year, CEO Francesco Siccardi reflects on the company's ongoing
commitment to medical education and innovation: "We are proud to celebrate our 25^th anniversary by continuing to
support our solutions and technologies through world-class medical education. Our dedication to advancing orthopedic
care is unwavering, and we remain focused on what matters the most: improving patient outcomes worldwide."
Medacta 25^th Anniversary World Tour concludes in Tokyo from October 12^th to 14^th.
For more information:
. Medacta's 10^th MORE International Symposium announcement
. Medacta's 10^th MORE International Symposium website
. Medacta's history
Contact
Gianluca Olgiati
Group Vice President Marketing
+41 91 696 60 60
media@medacta.ch
Medacta is a global key player specializing in the design, production, and distribution of innovative, personalized,
and sustainable solutions for joint replacement, sports medicine, and spine surgery. Established in 1999 in
Switzerland, Medacta is committed to improving the care and well-being of patients and maintains a strong focus on
healthcare sustainability. Through close collaboration with expert surgeons globally, continuous investments in R&D,
and the adoption of cutting-edge technologies, Medacta's innovation prioritizes minimally invasive surgery and
personalized solutions for every patient. Through the M.O.R.E. Institute, Medacta supports surgeons with a
comprehensive and tailored program dedicated to the advancement of medical education. Medacta is headquartered in
Castel San Pietro, Switzerland, and operates in over 60 countries. Follow us on Medacta TV, YouTube, LinkedIn and X.
RELATED TRADEMARKS
Medacta Group Related Trademarks are registered at least in Switzerland. The products and services listed below may not
be all-inclusive, and other Medacta products and services not listed below may be covered by one or more trademarks.
The below products and services may be covered by additional trademarks not listed below. Note that Swiss trademarks
may have foreign counterparts. MySolutionsT Personalized Ecosystem, NextART, GMK^®SpheriKA.
Additional features:
File: Medacta 25th Anniversary World Tour continues with events in Australia and the United States End of Media Release Language: English Company: Medacta Group SA
Strada Regina
6874 Castel San Pietro
Switzerland
Phone: +41 91 696 6060 E-mail: info@medacta.ch Internet: www.medacta.com ISIN: CH0468525222 Listed: SIX Swiss Exchange EQS News ID: 1913935
End of News EQS News Service
===
1913935 2024-05-30 CET/CEST
Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1913935&application_name=news
END) Dow Jones Newswires
May 30, 2024 13:00 ET (17:00 GMT)
